GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSL:AKBM) » Definitions » EV-to-EBIT

Aker BioMarine ASA (OSL:AKBM) EV-to-EBIT : 272.41 (As of May. 14, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aker BioMarine ASA EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Aker BioMarine ASA's Enterprise Value is kr10,592 Mil. Aker BioMarine ASA's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr39 Mil. Therefore, Aker BioMarine ASA's EV-to-EBIT for today is 272.41.

The historical rank and industry rank for Aker BioMarine ASA's EV-to-EBIT or its related term are showing as below:

OSL:AKBM' s EV-to-EBIT Range Over the Past 10 Years
Min: -16466.81   Med: 41.43   Max: 975.14
Current: 272.41

During the past 12 years, the highest EV-to-EBIT of Aker BioMarine ASA was 975.14. The lowest was -16466.81. And the median was 41.43.

OSL:AKBM's EV-to-EBIT is ranked worse than
98.78% of 1474 companies
in the Consumer Packaged Goods industry
Industry Median: 13.955 vs OSL:AKBM: 272.41

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Aker BioMarine ASA's Enterprise Value for the quarter that ended in Mar. 2024 was kr9,555 Mil. Aker BioMarine ASA's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr39 Mil. Aker BioMarine ASA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 0.41%.


Aker BioMarine ASA EV-to-EBIT Historical Data

The historical data trend for Aker BioMarine ASA's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aker BioMarine ASA EV-to-EBIT Chart

Aker BioMarine ASA Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 72.88 134.17 21.47 -1,499.70

Aker BioMarine ASA Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.55 38.00 31.61 -1,499.70 245.73

Competitive Comparison of Aker BioMarine ASA's EV-to-EBIT

For the Packaged Foods subindustry, Aker BioMarine ASA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aker BioMarine ASA's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aker BioMarine ASA's EV-to-EBIT falls into.



Aker BioMarine ASA EV-to-EBIT Calculation

Aker BioMarine ASA's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=10592.009/38.882
=272.41

Aker BioMarine ASA's current Enterprise Value is kr10,592 Mil.
Aker BioMarine ASA's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aker BioMarine ASA  (OSL:AKBM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Aker BioMarine ASA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=38.882/9554.5162
=0.41 %

Aker BioMarine ASA's Enterprise Value for the quarter that ended in Mar. 2024 was kr9,555 Mil.
Aker BioMarine ASA's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aker BioMarine ASA EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Aker BioMarine ASA's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Aker BioMarine ASA (OSL:AKBM) Business Description

Traded in Other Exchanges
Address
Oksenoyveien 10, P.O. Box 496, Lysaker, NOR, NO-1327
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.

Aker BioMarine ASA (OSL:AKBM) Headlines

No Headlines